Yuting’s practice focuses on government and internal investigations, cross-border litigation, and economic sanctions and export controls. She has represented a number of major banks and listed companies in trademark infringement and securities litigation cases before courts of the United States, and advised banks and multinational enterprises on economic sanctions and export controls risks. Yuting has experience in assisting financial institutions in responding to investigations relating to government sanctions. In addition, she has regularly advised multinational enterprises in healthcare, pharmaceutical, and other fields of life sciences in connection with internal investigations.

Prior to joining MoFo, Yuting worked at a leading international law firm for three years. She completed an externship at the United States District Court for the Eastern District of New York

Yuting is fluent in Mandarin and English.

Representative Experience

Litigation and Arbitration

• Five major Chinese banks in a trademark infringement matter in a U.S. federal court requesting non-party clients to provide documents.
• A U.S.-listed Chinese company in securities litigation in federal and state courts. Obtained dismissal in state court with prejudice.
• A leading Chinese education company in its international arbitration before the Hong Kong International Arbitration Center.
• A U.S.-listed Chinese online broker in securities litigation in federal and state courts. Obtained dismissal with prejudice.
• Five major Chinese banks in the Southern District of New York against a motion seeking sanctions of US$130 million.
• Achieved a favorable settlement for a leading Chinese media company in relation to a copyright infringement dispute.

Investigations, Government Enforcement, and White Collar Defense

• A multinational pharmaceutical company in a series of internal investigations, involving bribery, falsification of books and records, bid rigging, and other matters.
• A multinational medical devices company in internal investigations relating to the U.S. Foreign Corrupt Practices Act.
• A U.S.-listed Chinese education company in a government enforcement action initiated by the U.S. SEC related to potential securities fraud and other misconduct.
• An American multinational healthcare company in connection with FCPA related internal investigations.
• A multinational pharmaceutical company in connection with FCPA related internal investigations.

Economic Sanctions and Export Controls

• A major Chinese bank in a government enforcement action initiated by the U.S. DOJ regarding potential violations of U.S. sanctions.
• A multinational communications enterprise in its internal compliance with economic sanctions and export controls.